The Office for National Statistics (ONS) is due to publish its most up-to-date survey on share ownership in mid-January, which identifies the beneficial owners and decision- makers of the stock market. Hardman & Co has worked together with the share analysis service, Argus Vickers, to jointly produce its own survey, which anticipates the conclusions of the ONS survey but goes into much greater detail. Our work does not use a sample of 200 quoted companies as the ONS historically has, but rather includes everyUK quoted company. The ONS samples share registers every two years; our study uses six-monthly data points. Our survey also extends to shareholders on NEX; the ONS does not.
10 Jan 2020
THE MONTHLY January 2020
Advanced Oncotherapy, 39.0 | Allergy Therapeutics, 11.6 | Arbuthnot Banking Group, 1,085 | Burford Capital, 602 | Chamberlin, 24.0 | City Of London Investment Group, 468 | Diurnal Group, 28.0 | Filta Group, 155 | Genedrive, 9.0 | Morses Club, 118 | Non-Standard Finance, 31.5 | Palace Capital, 320 | Pantheon International, 2,500 | Primary Health Properties, 162 | Real Estate Credit Investments, 171 | RM Secured Direct Lending, 97.5 | Surface Transforms, 27.5 | 600 Group, 14.1 | Urban Logistics REIT, 147 | Volta Finance, 653
-
-
-
Hardman & Co Research Team
-
40 pages
-
.png)
